We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Highly Sensitive Molecular Test Developed for Tuberculosis

By LabMedica International staff writers
Posted on 15 Sep 2014
Print article
Image: The SD TB Ag MPT64 rapid immunochromatographic test for Mycobacterium tuberculosis (Photo courtesy of SD Bioline).
Image: The SD TB Ag MPT64 rapid immunochromatographic test for Mycobacterium tuberculosis (Photo courtesy of SD Bioline).
Rapid, accurate detection of Mycobacterium tuberculosis is crucial in the diagnosis of tuberculosis (TB), but conventional diagnostic methods have limited sensitivity and specificity or are time consuming.

A new highly sensitive nucleic acid amplification (NAA) test, combined nested and real-time polymerase chain reaction (PCR) in a single tube, one-tube nested real-time PCR, was developed for detecting M. tuberculosis, which takes advantages of two PCR techniques, including real-time PCR.

Biomedical Laboratory Scientists at Yonsei University (Wonju, Republic of Korea) and their colleagues collected sputum specimens from 167 subjects having active TB and from 108 healthy subjects. Sputum specimens were liquefied and processed and the sediment were suspended in sterile saline and used for smear preparation, inoculation into Löwenstein-Jensen (LJ) media and DNA extraction. The presence of acid fast bacilli (AFB) was examined using a light microscope and the results of AFB smear were graded.

Initial identification of M. tuberculosis was confirmed using the SD TB Ag MPT64 immunochromatographic test (SD Bioline Inc.; Yongin, Korea) and the REBA Myco-ID molecular diagnostic kit (M&D Inc.; Wonju, Korea). The scientists designed a one-tube nested real-time PCR to have two sequential reactions with two sets of primers and dual probes for the IS6110 sequence of M. tuberculosis in a single closed tube. A real-time PCR assays were performed and validated using an Applied Biosystems 7500 Fast Real-time PCR System (Foster City, CA, USA).

The minimum limits of detection of IS6110 real-time PCR was 100 fg/μL and for the IS6110 one-tube nested real-time PCR it was 1 fg/μL of M. tuberculosis DNA. AdvanSure TB/NTM real-time PCR (LG Life Science; Seoul, Korea), IS6110 real-time PCR, and one-tube nested real-time PCR showed 100% sensitivity and 100% specificity for clinical M. tuberculosis isolates and nontuberculous mycobacteria (NTM) isolates. In comparison, the sensitivities of AdvanSure TB/NTM real-time PCR was 91% (152/167), 94.6% (158/167) for the single IS6110 real-time PCR, and 100% (167/167) one-tube nested real-time PCR.

The authors concluded that the new efficient, highly sensitive PCR assay, one-tube nested real-time PCR targeting IS6110 sequence that was developed for detecting M. tuberculosis, utilizes the advantages of nested PCR and real-time PCR. One-tube nested real-time PCR showed superior sensitivity to conventional real-time PCR and AdvanSure TB/NTM real-time PCR, a commercial TB real-time PCR kit. The study was published on August 30, 2014, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Yonsei University 
SD Bioline Inc.
M&D Inc.



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.